2 completed, 1 withdrawn. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
Follow Inflazome UK Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PK Study in Patients With Parkinson's Disease With IZD174 IZD174 - Parkinson Disease | Phase 1 | Withdrawn | Inflazome UK Ltd | 2020-10-01 | 2020-12-04 | |
| Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334 IZD334, Placebos - Healthy Volunteers, Cryopyrin Associated Periodic Syndrome | Phase 1 | Completed | Inflazome UK Ltd | 64 | 2019-09-13 | 2020-03-02 |
| Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With Inzomelid Inzomelid, Placebo - Healthy | Phase 1 | Completed | Inflazome UK Ltd | 80 | 2019-07-16 | 2020-03-27 |
Cryopyrin-Associated Periodic Syndromes (1) · Parkinson Disease (1)
Australia (2)
Ben Snyder, MB, BS (1) · Jason Lickliter, MBBS, PhD (1) · Teus van Laar, MD, PhD (1)